Literature DB >> 23448443

Tea and health: studies in humans.

Naghma Khan1, Hasan Mukhtar.   

Abstract

Tea, next to water is the cheapest beverage humans consume. Drinking the beverage tea has been considered a healthpromoting habit since ancient times. The modern medicinal research is providing a scientific basis for this belief. The evidence supporting the health benefits of tea drinking grows stronger with each new study that is published in the scientific literature. Tea plant Camellia sinensis has been cultivated for thousands of years and its leaves have been used for medicinal purposes. Tea is used as a popular beverage worldwide and its ingredients are now finding medicinal benefits. Encouraging data showing cancer-preventive effects of green tea from cell-culture, animal and human studies have emerged. Evidence is accumulating that black tea may have similar beneficial effects. Tea consumption has also been shown to be useful for prevention of many debilitating human diseases that include maintenance of cardiovascular and metabolic health. Various studies suggest that polyphenolic compounds present in green and black tea are associated with beneficial effects in prevention of cardiovascular diseases, particularly of atherosclerosis and coronary heart disease. In addition, anti-aging, antidiabetic and many other health beneficial effects associated with tea consumption are described. Evidence is accumulating that catechins and theaflavins, which are the main polyphenolic compounds of green and black tea, respectively, are responsible for most of the physiological effects of tea. This article describes the evidences from clinical and epidemiological studies in the prevention of chronic diseases like cancer and cardiovascular diseases and general health promotion associated with tea consumption.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448443      PMCID: PMC4055352          DOI: 10.2174/1381612811319340008

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  60 in total

Review 1.  Green tea consumption and breast cancer risk or recurrence: a meta-analysis.

Authors:  Adeyemi A Ogunleye; Fei Xue; Karin B Michels
Journal:  Breast Cancer Res Treat       Date:  2009-05-13       Impact factor: 4.872

2.  A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Authors:  Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

3.  A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Authors:  E Choan; Roanne Segal; Derek Jonker; Shawn Malone; Neil Reaume; Libni Eapen; Victor Gallant
Journal:  Urol Oncol       Date:  2005 Mar-Apr       Impact factor: 3.498

4.  Green tea consumption and colorectal cancer risk: a report from the Shanghai Men's Health Study.

Authors:  Gong Yang; Wei Zheng; Yong-Bing Xiang; Jing Gao; Hong-Lan Li; Xianglan Zhang; Yu-Tang Gao; Xiao-Ou Shu
Journal:  Carcinogenesis       Date:  2011-08-19       Impact factor: 4.944

5.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors:  Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes.

Authors:  Jaya Bharathi Vaidyanathan; Thomas Walle
Journal:  Drug Metab Dispos       Date:  2002-08       Impact factor: 3.922

Review 7.  Metabolism of green tea catechins: an overview.

Authors:  Wan Yong Feng
Journal:  Curr Drug Metab       Date:  2006-10       Impact factor: 3.731

8.  Association between green tea intake and coronary artery disease in a Chinese population.

Authors:  Qi-Ming Wang; Qing-Yue Gong; Jian-Jun Yan; Jun Zhu; Jian-Jin Tang; Ming-Wei Wang; Zhi-Jian Yang; Lian-Sheng Wang
Journal:  Circ J       Date:  2009-12-17       Impact factor: 2.993

9.  Characterization of interactions between polyphenolic compounds and human serum proteins by capillary electrophoresis.

Authors:  Andréa Diniz; Laura Escuder-Gilabert; Norberto P Lopes; Rosa María Villanueva-Camañas; Salvador Sagrado; María José Medina-Hernández
Journal:  Anal Bioanal Chem       Date:  2008-04-18       Impact factor: 4.142

10.  Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.

Authors:  E-K Tan; C Tan; S M C Fook-Chong; S Y Lum; A Chai; H Chung; H Shen; Y Zhao; M L Teoh; Y Yih; R Pavanni; V R Chandran; M C Wong
Journal:  J Neurol Sci       Date:  2003-12-15       Impact factor: 3.181

View more
  75 in total

1.  Influence of diet supplementation with green tea extract on drug-metabolizing enzymes in a mouse model of monosodium glutamate-induced obesity.

Authors:  Iva Boušová; Petra Matoušková; Hana Bártíková; Barbora Szotáková; Veronika Hanušová; Veronika Tománková; Eva Anzenbacherová; Barbora Lišková; Pavel Anzenbacher; Lenka Skálová
Journal:  Eur J Nutr       Date:  2015-02-08       Impact factor: 5.614

Review 2.  Dietary agents for prevention and treatment of lung cancer.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2015-01-30       Impact factor: 8.679

3.  Determination of free amino acids in tea by a novel method of reversed-phase high performance liquid chromatography applying 6-Aminoquinolyl-N-Hydroxysuccinimidyl carbamate reagent.

Authors:  Min Li; Daxiang Li; Yuling Tai; Chenchen Gu; Yasai Song; Weiting Jiao; Jingming Ning; Chaoling Wei; Xungang Gu; Chi-Tang Ho; Jamal U Ddin Hajano; Xiaochun Wan
Journal:  J Food Sci Technol       Date:  2018-08-25       Impact factor: 2.701

4.  Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.

Authors:  Naghma Khan; Dhruba J Bharali; Vaqar M Adhami; Imtiaz A Siddiqui; Huadong Cui; Sameh M Shabana; Shaker A Mousa; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2013-09-26       Impact factor: 4.944

5.  Utilization of microRNAs and their regulatory functions for improving biotic stress tolerance in tea plant [Camellia sinensis (L.) O. Kuntze].

Authors:  Anburaj Jeyaraj; Tamilselvi Elango; Xinghui Li; Guiyi Guo
Journal:  RNA Biol       Date:  2020-06-16       Impact factor: 4.652

6.  Association of green tea consumption with risk of coronary heart disease in Chinese population.

Authors:  Jun Pang; Zheng Zhang; Tongzhang Zheng; Yue-jin Yang; Na Li; Min Bai; Yu Peng; Jin Zhang; Qiang Li; Bo Zhang
Journal:  Int J Cardiol       Date:  2014-11-11       Impact factor: 4.164

7.  Correlation between tea consumption and prevalence of hypertension among Singaporean Chinese residents aged ⩾40 years.

Authors:  W Li; J Yang; X S Zhu; S C Li; P C Ho
Journal:  J Hum Hypertens       Date:  2015-05-28       Impact factor: 3.012

8.  Tea polyphenols protect bovine mammary epithelial cells from hydrogen peroxide-induced oxidative damage in vitro.

Authors:  Yanfen Ma; Lei Zhao; Min Gao; Juan J Loor
Journal:  J Anim Sci       Date:  2018-09-29       Impact factor: 3.159

9.  (-)-Epigallocatechin-3-gallate, the major green tea catechin, regulates the desensitization of β1 adrenoceptor via GRK2 in experimental heart failure.

Authors:  Qi Zhang; Liqun Hu; Li Chen; Hongqi Li; Jun Wu; Wenting Liu; Mengyuan Zhang; Guang Yan
Journal:  Inflammopharmacology       Date:  2017-12-16       Impact factor: 4.473

10.  Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men.

Authors:  Junxiu Liu; Shiwei Liu; Haiming Zhou; Timothy Hanson; Ling Yang; Zhengming Chen; Maigeng Zhou
Journal:  Eur J Epidemiol       Date:  2016-07-02       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.